Robeco Institutional Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $107M | Buy |
189,760
+3,633
| +2% | +$2.33M | 0.15% | 164 |
|
|
2025
Q4 | $126M | Sell |
186,127
-20,389
| -10% | -$13.9M | 0.18% | 137 |
|
|
2025
Q3 | $132M | Sell |
206,516
-712
| -0.3% | -$432K | 0.19% | 122 |
|
|
2025
Q2 | $111M | Buy |
207,228
+58,991
| +40% | +$28.2M | 0.18% | 132 |
|
|
2025
Q1 | $62.3M | Sell |
148,237
-24,091
| -14% | -$10.5M | 0.12% | 166 |
|
|
2024
Q4 | $71.2M | Sell |
172,328
-60,432
| -26% | -$26.5M | 0.14% | 150 |
|
|
2024
Q3 | $118M | Sell |
232,760
-3,395
| -1% | -$1.65M | 0.23% | 98 |
|
|
2024
Q2 | $115M | Sell |
236,155
-45,315
| -16% | -$22.7M | 0.25% | 91 |
|
|
2024
Q1 | $152M | Buy |
281,470
+31,054
| +12% | +$17M | 0.33% | 67 |
|
|
2023
Q4 | $139M | Sell |
250,416
-26,486
| -10% | -$12.4M | 0.34% | 71 |
|
|
2023
Q3 | $121M | Sell |
276,902
-8,924
| -3% | -$4.45M | 0.32% | 75 |
|
|
2023
Q2 | $144M | Buy |
285,826
+8,506
| +3% | +$4.08M | 0.38% | 66 |
|
|
2023
Q1 | $139M | Buy |
277,320
+19,387
| +8% | +$9.28M | 0.38% | 71 |
|
|
2022
Q4 | $105M | Sell |
257,933
-87,555
| -25% | -$34M | 0.3% | 90 |
|
|
2022
Q3 | $113M | Buy |
345,488
+47,355
| +16% | +$17.4M | 0.36% | 72 |
|
|
2022
Q2 | $105M | Sell |
298,133
-42,243
| -12% | -$17.2M | 0.32% | 79 |
|
|
2022
Q1 | $186M | Sell |
340,376
-16,905
| -5% | -$8.89M | 0.44% | 56 |
|
|
2021
Q4 | $235M | Buy |
357,281
+86,273
| +32% | +$54.2M | 0.5% | 48 |
|
|
2021
Q3 | $169M | Sell |
271,008
-41,865
| -13% | -$28.1M | 0.37% | 69 |
|
|
2021
Q2 | $198M | Sell |
312,873
-38,768
| -11% | -$21.4M | 0.44% | 56 |
|
|
2021
Q1 | $172M | Buy |
351,641
+16,255
| +5% | +$8.14M | 0.42% | 56 |
|
|
2020
Q4 | $168M | Buy |
335,386
+33,328
| +11% | +$14.9M | 0.44% | 56 |
|
|
2020
Q3 | $119M | Buy |
302,058
+33,862
| +13% | +$12.5M | 0.37% | 73 |
|
|
2020
Q2 | $88.5M | Sell |
268,196
-32,596
| -11% | -$9.44M | 0.3% | 87 |
|
|
2020
Q1 | $72.9M | Buy |
300,792
+104,069
| +53% | +$27.2M | 0.29% | 82 |
|
|
2019
Q4 | $51.4M | Buy |
196,723
+135,058
| +219% | +$35.6M | 0.16% | 173 |
|
|
2019
Q3 | $16.8M | Sell |
61,665
-864
| -1% | -$240K | 0.06% | 347 |
|
|
2019
Q2 | $17.2M | Sell |
62,529
-8,839
| -12% | -$2.18M | 0.06% | 360 |
|
|
2019
Q1 | $16M | Sell |
71,368
-50,858
| -42% | -$10.5M | 0.06% | 386 |
|
|
2018
Q4 | $22.7M | Sell |
122,226
-33,179
| -21% | -$6.8M | 0.1% | 262 |
|
|
2018
Q3 | $38.8M | Buy |
155,405
+8,243
| +6% | +$2M | 0.15% | 180 |
|
|
2018
Q2 | $32.1M | Buy |
147,162
+3,248
| +2% | +$669K | 0.15% | 181 |
|
|
2018
Q1 | $27.5M | Sell |
143,914
-18,049
| -11% | -$3.33M | 0.13% | 212 |
|
|
2017
Q4 | $25.3M | Buy |
161,963
+4,942
| +3% | +$778K | 0.13% | 196 |
|
|
2017
Q3 | $24.4M | Buy |
157,021
+7,176
| +5% | +$1.13M | 0.15% | 176 |
|
|
2017
Q2 | $24.2M | Buy |
149,845
+22,180
| +17% | +$3.6M | 0.16% | 170 |
|
|
2017
Q1 | $19.7M | Buy |
127,665
+4,662
| +4% | +$643K | 0.13% | 189 |
|
|
2016
Q4 | $14.4M | Buy |
123,003
+13,251
| +12% | +$1.51M | 0.11% | 217 |
|
|
2016
Q3 | $12.4M | Buy |
109,752
+108,976
| +14,043% | +$11.5M | 0.09% | 244 |
|
|
2016
Q2 | $72K | Buy |
+776
| New | +$66.6K | ﹤0.01% | 756 |
|
Other funds holding IDXX
VCM
VPM
Robeco Institutional Asset Management's IDXX Position: Q1 2026 in Review
Robeco Institutional Asset Management increased its Idexx Laboratories (IDXX) stake by 2% in Q1 2026, buying an estimated $2.33M and bringing the position to 189,760 shares worth $107M. The position accounts for 0.15% of the portfolio, ranked #164.
Robeco Institutional Asset Management first reported a position in IDXX in Q2 2016 and has held it in 40 quarters since. The position peaked at $235M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Robeco Institutional Asset Management held 189,760 shares of Idexx Laboratories worth $107M as of Q1 2026.
- Robeco Institutional Asset Management bought 3,633 Idexx Laboratories shares in Q1 2026, an estimated $2.33M.
- Idexx Laboratories made up 0.15% of Robeco Institutional Asset Management's portfolio in Q1 2026, its #164 holding.
- Robeco Institutional Asset Management first reported a position in Idexx Laboratories in Q2 2016 and has held it in 40 quarters since.
- Robeco Institutional Asset Management's Idexx Laboratories position peaked at $235M in Q4 2021.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Robeco Institutional Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.